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Abstract
Respiratory processes that take place in childhood (preschool and adolescence) have a 
predominant frequency, especially rhinitis and asthma. Family predisposition and the 
environment define the characteristics of the endotype and the phenotype. Heritage, both 
of the genes related to bronchial hyperresponsiveness and those related to atopy (produc-
tion of specific IgE against allergens and hypereosinophilia) are the fundamental basis of 
those processes that begin at preschool age and continue into adulthood if they do not 
receive early and etiological treatment. The physiological vagal hyperresponsiveness of 
the infant; the environment in which it develops, even from the prenatal phase (pregnant 
smoker); and viral infections are responsible for frequent bronchial processes in the early 
years that, sometimes, also extend into adolescence. In summary, the coordination of the 
endotype and the phenotype has led to the acknowledgement and acceptance of these 
three tracheobronchial processes: transient early wheezing, non-atopic wheezing, and 
atopic wheezing/asthma.
Keywords: children, phenotype, endotype, bronchospasm, wheezing, asthma
1. Introduction
The phenotype is defined as “observable characteristic with no direct relationship to a disease 
process, including physiology, triggers and inflammatory parameters” and the endotype as 
“distinct disease entities which may be present in cluster of phenotypes, but each defined by 
a specific biological mechanisms.” [1, 2].
The variability of bronchopulmonary processes that take place in childhood makes it difficult 
to establish the criteria for the definition of asthma and, therefore, the phenotype. Age is one 
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of the most important determinants of the phenotype in early childhood and adolescence, 
including determinants from genetics to the environment. In early childhood, airway develop-
ment, the environment (especially pregnant smoker), and frequent viral infections, without a 
doubt, have a decisive influence to establish the phenotype. Symptomatology and lung func-
tion (especially the specific airway resistance, atopy, and airway hyperresponsiveness (AHR) 
at age of 3–5 years) identify several groups of variants: only wheeze, wheeze with irritants, 
chest congestion and cough, wheeze with allergens that correlate to atopy, and AHR. Asthma 
that began at those ages, usually preceded by rhinitis, usually lasts until adolescence, if an 
adequate treatment was not carried out, especially based on the etiology (immunotherapy). 
In some cases, at that age, the causality may be different, environment and acquired habits 
(especially smoking) that lead to inflammation of the airways, similar to what occurs in adults 
(occupational asthma). Three variants have been proposed based on the endotypes: mild to 
intermittent asthma, asthma with severe exacerbations and multiple allergens, and severe 
obstructive asthma with neutrophilia [2, 3].
Allergic diseases can be predicted taking into account the key factor in their onset, genetic 
predisposition, since it is inherited as autosomal dominant trait. Knowledge that at least one 
of the parents suffers from an allergic disease is a factor to consider. In fact, it is the most reli-
able indicator for predicting predisposition, although not sufficient to predict it accurately. If 
both parents are allergic, and even more if they are asthmatic, the risk of allergic respiratory 
disease can be predicted even better. Although the existence of first-degree relatives suffering 
from allergic disease is considered the most valuable data, among many others that have been 
studied, the degree of reliability can be specified as 50% of cases.
2. Genetic predisposition: chromosomes and genes involved
The allergic predisposition (atopic) is of a polygenic nature, that is to say, the genes that sup-
port the polymorphisms that give rise to the body’s abnormal response to substances (aller-
gens) that are well tolerated by most people and which originate the production of specific 
IgE antibodies (reagins) against proteins with antigenic capacity contained therein. Even with 
no atopic predisposition, at any age, excessive exposure to allergens equally can cause specific 
IgE production, with consequent clinical translation.
The genetic basis of asthma is not unique, but depends on a complex polymorphism, and it is 
not strange that the involvement of the various genes that are supposed to be implicated is not 
yet known. The allergic reaction is linked to the predominance of Th2 lymphocyte activity and 
the subsequent increase in specific IgE. Chromosome 11 (11q13) was the first to identify genes 
involved in its production; in it lies the synthesis of the β chain of the high-affinity IgE receptor.
It is estimated that at least 100 genes are involved in the pathogenesis of atopy and asthma. 
Some 30 loci on various chromosomes have been linked on the one hand with the function of 
the airways and another on the production of IgE [4, 5]. Chromosome 5 (5q31-q33) contains 
the genes that modulate the production of interleukins secreted by Th2 lymphocytes, such as 
IL-4 and IL-13, responsible for the atopic response when involved in the secretion of IgE by 
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B lymphocytes (plasma cells), as well as other interleukins (IL-3, IL-5, IL-9) which also inter-
vene. In addition, in the same gene, the protocadherin-1 (PCDH1) that could alter the integ-
rity of the bronchial epithelium, the first line of defense against inhalation of environmental 
substances, has been identified [6]. On the other hand, the onset of asthma in the pediatric 
age has linked to chromosome 17q21, the main genetic determinant of the ORMDL3 gene that 
encodes endoplasmic reticulum proteins, and has also been associated with poor outcome in 
children exposed to environmental irritants, especially tobacco smoke [7, 8].
Logically, genes related to the allergic reaction are common to other allergic processes, such 
as those caused by food or drugs mainly, which may be the cause of dermatological (eczema, 
urticaria), digestive, or anaphylactic processes. Sometimes, because of the same, there is aller-
gic rhinitis, but it must be taken into account that it is not always an exclusive manifestation 
of the allergy but at the same time, the genes involved in the pulmonary function (airway 
hyperresponsiveness) can intervene. In these cases, rhinitis precedes asthma, as in many cases 
eczema manifests itself early in infants who later suffer from asthma.
Based on these data, the respiratory processes of allergy cause are rhinitis, tracheobronchitis, 
and asthma.
3. Respiratory processes
3.1. Rhinitis
The respiratory mucosa shows structural and functional homogeneity in all areas where it is 
found with the exception of greater vascularization in the nasal area. Its specific function lies 
in providing a defense against the noxious agents that so abundantly penetrate through the 
airways. The entire inner layer of the airway participates in the ciliary defense system with 
which the epithelial cells are endowed, in addition to the various mucosal glands and cells of the 
immune system, present in the subepithelial layer throughout the mucous membrane. Likewise, 
it can present a unified response, although in different ways, against allergens in individuals 
with an atopic disposition. For this reason, allergic disease is commonly manifested by symp-
toms that affect the entire mucosa (rhinitis, asthma, rhinosinusitis, rhinoconjunctivitis), although 
frequently only a partial stretch is affected, with symptoms exclusive to the upper airway.
In most asthma cases, children display rhinitis or rhinopharyngitis during some time prior to 
symptoms at lower levels of the respiratory tract. Even at birth or in the first months of life, 
children can display symptoms of allergic rhinitis, although at that age specific sensitization 
can hardly be demonstrated. The symptoms that can precede the onset of asthma are hydror-
rhea, nasal congestion, and sneezing. Later, when asthma is treated correctly and symptoms 
disappear, rhinitis symptoms—albeit mild—tend to remain as an aftermath.
3.2. Tracheobronchitis
If the concept of asthma is based on the occurrence of dyspnea (shortness of breath is pre-
ponderant), episodes of coughing and breathing noises can also lead to an asthma diagnosis. 
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In many cases (at any age) coughing is productive, and low wheezing is detected by ausculta-
tion, sometimes due to tracheobronchial obstruction by mucus secretion or by some degree 
of constriction of the smooth bronchial muscle. Asthmatic children sometimes display these 
same symptoms, alternating with dyspnea episodes (Table 1).
3.3. Asthma
Even under proper treatment conditions, asthma is usually persistent. Patients experience 
unexpected relapses, although most children experience clear and progressive improvement, 
both in terms of seizure frequency and intensity. The speed of improvement largely depends 
on the prognostic outlook. Many children stop having attacks shortly after starting hyposensi-
tization treatment, and in these cases, a positive prognosis is highly likely. However, another 
non-negligible group in the framework of undeniable improvement displays a greater ten-
dency to relapse, sometimes as a result of seemingly banal respiratory processes caused by 
epidemic viral infections or nonspecific triggers, such as change in the weather, overexertion, 
or exposure to environmental contaminants. In general terms, without a solid underlying 
statistical basis, it has been estimated that in 75% of cases, childhood asthma is benign and 
subject to good prognosis, 20% of asthmatic children suffer from a mild form, and the remain-
ing 5% suffer from severe asthma. Children in this 25% group are therefore most likely to 
suffer from asthma in adulthood [4, 5]. In any case, we must bear in mind that wheezing is a 
common symptom in other processes which should be considered (Table 2).
Cough Whistling rales Dyspnea Expectoration
Rhinopharyngitis Tracheobronchitis Wheezing bronchitis Chronic bronchitis
Sinusitis Foreign body Bronchiolitis Bronchiectasis
Adenoiditis Mucoviscidosis Gastro-oesophageal reflux Pneumonia
Whooping cough Bronchiectasis Extrinsic allergic alveolitis Mucoviscidosis
Tracheobronchitis Hemosiderosis Extra-tracheobronchial: Hemosiderosis
Laryngitis Lymphadenopathy • Pleuritis COPD
Bronchitis Pulmonary cysts • Pneumonia
Bronchiectasis Immotile cilia syndrome • Tuberculosis
Foreign body Lobular emphysema • Pulmonary edema
Gastrooesophageal reflux Tracheoesophageal fistula • Etc.
Inhalation of irritating 
gases
Eosinophilic bronchitis
Eosinophilic bronchitis
COPD
Psychogenic
Table 1. Common tracheobronchial symptoms and more frequent processes (other than asthma).
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Several follow-up studies over several years reach different conclusions in the numbers of 
asthma persisting in adulthood. These differences can be explained by the different criteria 
taken into account for estimating the persistence of the disease, in addition to the different 
conditions of patients’ lives, such as the workplace, smoking, climate, urban or rural liv-
ing, etc. It is known that broncholability (airway hyperresponsiveness) persists indefinitely, 
although with proper and early treatment it can decrease significantly. This weakness can be 
displayed in unfavorable situations, such as a viral infection and excessive exposure to envi-
ronmental pollutants, with the onset of sporadic respiratory symptoms (wheezing) which 
should not be labeled as asthma and much less be interpreted as asthma relapse.
It is difficult to establish a prognosis beforehand, although some data are available to evaluate 
it. The immune system matures throughout childhood, so most infections occur in the early 
years of life. Depending on their environment, children may experience up to a hundred infec-
tions in their first 8 or 10 years of life, i.e., an average of one infection per month, so that the 
immune system receives sufficient stimuli for maturation. While they do not always appear 
with a very striking clinical picture, these respiratory tract infections can trigger bronchial 
obstructions of varying intensity. This can result in the false diagnosis of asthma, without the 
existence of a hypersensitivity reaction or inflammation that leaves permanent side effects. As 
the defense system matures when a child is between 6 and 8, the child stops experiencing bron-
chial obstruction, and these “false asthma patients” will be the ones who heal spontaneously.
Some endocrine system maturational factors (still undetermined) in some children boost an 
improvement around puberty, more evident in boys than in girls. But this improvement is 
only apparent. In most cases it is not uncommon for more or less mild symptoms to appear 
sporadically, sometimes during physical exercise, in addition to other minor symptoms such 
as rhinitis or eczema, when present. The typical physical and psychological changes during 
Common Asthma
Gastroesophageal reflux
Infections: bronchiolitis, bronchitis,
pneumonia, upper respiratory
Uncommon Bronchopulmonary dysplasia
Foreign body aspiration
Rare Bronchiolitis obliterans
Congenital vascular abnormalities
Cystic fibrosis
Immunodeficiency diseases
Mediastinal masses
Primary ciliary dyskinesia
Tracheobronchial anomalies
Vocal cord dysfunction
Table 2. Causes of wheezing in children.
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this age make asthma patients often underestimate their symptoms and abandon treatment. 
However, spirometry tests often reveal impaired respiratory function, to varying degrees, 
predominantly affecting peripheral bronchi (“small airways”), evidenced by the reduced 
mid-expiratory flow.
To make a prognosis, the location of bronchial obstruction must be determined, and it is not 
detectable when the respiratory function is checked only by measuring the peak expiratory 
flow (PEF). The obstruction of peripheral bronchi is an indicator of poor outcome. It has even 
become established that this data may have prognostic value, so that 7-year-old children with-
out asthma are more likely to develop asthma in the following 6 years if their average expira-
tory flow is lower than normal. Expanding on this concept, the reduction of mean flow at that 
age also predicts the persistence of asthma in adults, 25 years later.
3.3.1. Pathogenesis
Asthma is a disease whose onset in childhood has, in most cases, a genetic factor of not only 
allergic predisposition (production of specific IgE against allergens and eosinophilia) but also 
factors responsible for airway hyperresponsiveness (AHR). In other cases, especially of later 
onset, bronchial inflammation, with initial involvement of the respiratory mucosa, asthma is 
a consequence of environmental irritants or viral infection, in which case neutrophilic is the 
dominant.
In the pathogenesis of asthma, bronchospasm occurs first aided by the AHR, and it is what 
characterizes the initial phase of asthma attack. Airway smooth muscle contraction involves 
the formation of actin-myosin cross bridges with the rate of formation dependent upon the 
activity of myosin light chain kinase and myosin light chain phosphatase. Subsequently, the 
release of various proteolytic enzymes of eosinophils (ECP, MBP, EPO, EPX) and phospho-
lipid metabolites (LT, PG, TX) triggers the inflammatory reaction, which is responsible of the 
prolongation of the crisis as well as the chronicity of the process. Congenital AHR is the con-
sequence of several mutations in the genes encoding β
2
-adrenergic receptors of the bronchial 
smooth muscle, related to the greater sensitivity of the same in the people affects due to the 
mutation. The consequence of this mutation is the α-adrenergic (constrictor)/β-adrenergic 
(relaxant) imbalance. In addition, mast cells have been demonstrated in the bronchial smooth 
muscle of these patients, which undoubtedly have a predominant role in the hyperresponsive-
ness when the mediators responsible for bronchial smooth muscle constriction and the attrac-
tion of eosinophils and neutrophils (histamine, tryptase, chymase) and later those involved in 
the inflammatory reaction (leukotrienes, prostaglandins, thromboxanes) are relapsed [1, 2].
Genetic predisposition (endotype) can be based either in the mutation that leads to congenital 
AHR or the multiple factors affecting atopic. The coincidence to both genetic backgrounds 
determines the early onset of rhinitis/asthma which has led to the conception of different 
phenotypes. Family atopy is a key factor for the onset of allergic disease in infancy, but the 
absence of AHR, sometimes, is manifested by skin, digestive, or anaphylactic (food, drug) 
reactions. If the family atopic predisposition is absent, the AHR that can be secondary to 
environmental factors will also be basic in the pathogenesis of asthma that in these cases, the 
onset will be later.
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The AHR is responsible for acute and sporadic bronchospasm (episodes of dyspnea). The 
other symptoms, not sporadic, but habitual of greater or less intensity depending of the grav-
ity, environment, and treatment, are mainly due to the inflammation that accompanies the 
process, whose cause differs in different circumstances [5–10].
Dominant symptoms, age of onset, persistence, and causes (viruses, allergens, environmental 
irritants) are the factors that influence the variability of phenotypes, not always persistent 
from childhood to adulthood, which undoubtedly differentiate the process at the different 
stages of life.
3.3.2. Prognostic criteria
The beforehand assessment of disease progression can be established based on the following 
data: family history, child-dependent factors, environment, disease characteristics, and early 
and correct treatment. The sum of unfavorable data worsens prognosis.
Family genetics, especially parental, increases the risk proportionally to the acuteness of the 
allergic process (asthma, eczema). Moreover, immunodeficiencies must be taken into account. 
They favor respiratory infections, especially selective IgA deficiency, which is present very 
often due to hypersensitivity reactions, perhaps due to an immune compensation mecha-
nism. Within the environment, both the location of the home and the atmosphere within the 
home may have a significant influence. In terms of age of onset, it should be noted that in the 
first 2 or 3 years of life, episodes of shortness of breath may occur due to various anatomical-
physiological causes (immune immaturity, bronchial constriction, vagal tone) which result 
in narrowing of the bronchial lumen in various circumstances. This should not be labeled 
as asthma. Thus, it is estimated that between 45 and 85% of these children in a few years 
will no longer exhibit symptoms. They are considered “false asthma patients” who will heal 
spontaneously. The possibility exists for the child to suffer from rhinovirus-induced bronchi-
olitis leading to significant desquamation of bronchial epithelium and inflammatory reaction 
which facilitates the passage of pneumo-allergens leading to sensitization, even in the absence 
of prior atopic predisposition.
Sensitization to multiple allergens is another cause of poor outcome, especially if these involve 
a fungus. These microorganisms result in a type of asthma which is more difficult to control. 
With regard to an atopic predisposition, suffering from several allergic diseases is another 
cause of poor outcome. Atopic eczema is the most influential, in direct proportion to how 
extensive and stubborn it is.
3.3.3. Evolutionary criteria
Not all children with wheeze at early age will have asthma later; the sex also influences the 
natural evolution of the process with a shift in severity and prevalence biased toward women 
after puberty (Table 3).
In summary, the evolution of the process can be summarized as follows:
Good evolution: decrease in the number of asthma attacks in 1 year to half or less than the previ-
ous year, respiratory function within normal limits.
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Moderate evolution: decrease in the number of attacks in 2 years to at least half of the previous 
year at the start of treatment, improving the intensity of attacks and maintaining an accept-
able respiratory function.
Poor evolution: the number and intensity of attacks do not change, and the respiratory function 
does not improve but actually tends to worsen, with FEF
1
 between 70 and 80% of predicted 
and FMF25–75 between 40 and 60% of forecast.
Deterioration: aggravation of the crisis in frequency and/or intensity, with impaired respira-
tory function: FEV
1
 < 80% and FMF25–75 < 60% of forecast.
3.3.4. Healing criteria
Atopic genetic predisposition is not modified by any therapeutic measure, but clinical signs 
can be suppressed in a large number of patients with appropriate preventive measures and 
early treatment, targeting primarily causal aspects (immunotherapy can partly correct the 
altered immune response).
The clinical criterion is possibly the most valuable with regard to how long the child must be 
free of symptoms, particularly dyspnea, since sometimes children unexpectedly relapse after a 
long time of being symptom-free. A widely accepted period of time is 2 years without an attack.
In parallel to the absence of subjective clinical symptoms, the objective assessment of the 
respiratory function (spirometry tests) is another data factor that must unavoidably be taken 
into account. This is because children cannot be considered asthma-free if bronchial obstruc-
tion persists, although they may be free from obvious symptoms. Certainly, a child with alter-
ations in spirometric values cannot be considered risk-free.
Age (year)
<5 5–11 12–18
Prevalence by sex M > F M > F Before puberty: M > F
After puberty: F > M
Predominant effector 
cell
Neutrophil
Eosinophil
Eosinophil Eosinophil
Reticular basement 
membrane
Begins after the 
first birthday
Not as thick as adults Thickening approaches that are seen in 
adults
Lung function Measures difficult 
to obtain
Changes associated 
with duration of asthma 
symptoms
Deficits present in those patients who began 
wheezing before age 3 but might not present 
in those who began wheezing in later 
childhood
Incidence of 
exacerbations
++++ +++ ++
Taken from Szefler et al. [11].
Table 3. Pathophysiologic changes of asthma by age.
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Table 4 shows the different data to be assessed after the etiological treatment (immunother-
apy), the results of which will depend on the asthma cure criteria. This brings changes in the 
immune response (reduction of IgE, increase in IgG
1
-IgG
4
, and increase in Th1 lymphocytes), 
together with the decrease in histamine. Bronchial hyperresponsiveness, however, is main-
tained, although reduced by elimination or reduction of bronchial inflammation, which in 
itself does not represent a risk of relapse, as it is verified after an average of 10 years after the 
medical discharge [12].
4. Preschool children
Some anatomo-physiological characteristics of the airways of infants and young children pre-
dispose to the occurrence of processes that lead to narrowing or bronchial obstruction, which 
are manifested by common symptoms, such as cough, dyspnea, and noise or wheezing.
The smaller bronchial caliber is a basic fact that facilitates the obstruction, as a consequence 
of the inflammation of the mucosa, of the constriction of the smooth muscle or of the increase 
of the secretion of the tracheobronchial mucous glands. Also known is the physiological vagal 
tone of the infant, which lasts during the first years of life. Pathologically, bronchial hyper-
responsiveness is a fundamental fact in the pathogenesis of asthma. This AHB, by stimulation 
of the bronchial smooth muscle, is usually secondary to the inflammatory reaction that takes 
place in various circumstances in the bronchial mucosa, but it is also a characteristic of indi-
viduals with atopic predisposition, since there are certain abnormalities in the protein chain of 
the β-receptors of the smooth muscle.
In relation to the infectious bronchopulmonary disease, so frequent in the first years of life, 
there is the well-known immaturity of the immune system, which in some children last for 
several years (transient immunodeficiency of the infant), facilitating the appearance of bron-
chial inflammatory processes, which they manifest with symptoms partly common to other 
Chronological 2 years without crisis
Functional Absence of signs of bronchial obstruction (large and small airways)
Airway hyperresponsiveness Decreased response to allergen inhalation
Decreased response to methacholine or histamine inhalation
Decreased response to physical exercise
Immunoallergics Decreased response to prick test
Decrease of total IgE
Increase of IgG (IgG
1
–IgG
4
)
Increase of Th1 lymphocytes
Decrease of basophil degranulation (decrease of histamine release)
Table 4. Asthma healing criteria.
Meaning of Endotype-Phenotype in Pediatric Respiratory Pathology
http://dx.doi.org/10.5772/intechopen.75029
43
tracheobronchial processes. The inflammation of the small airways is correlated with the exis-
tence of exhaled nitric oxide (FeNO) whose values have been proposed for the diagnostic con-
firmation of asthma, even up to school age because it is considered as a potential biomarker 
to distinguish endotypes. However, despite its strong correlation with atopy, it seems that it 
can only be considered as a biomarker for transient wheezing but not for persistent wheezing 
phenotypes.
Viral infections (respiratory syncytial virus (RSV) and rhinovirus (RV)) are a frequent cause 
of respiratory processes in young children, often transient (bronchiolitis), although in some 
cases the persistence of chronic inflammation, disrupted epithelium, and airway remodeling 
can condition the major bronchoconstrictor response to environmental irritants and, espe-
cially, to allergens, causing asthma [13].
With this background, it is not uncommon for processes of different causality to manifest 
clinically with similar symptoms, which can lead to erroneous diagnoses, if the knowledge 
of differential signs is not in-depth, such as genetic background, habits, and family environ-
ment, among others (Table 5).
Dominant symptom: cough Maxillary sinusitis
Adenoid vegetations
Rhinopharyngitis
Whooping cough
Primary ciliary dyskinesia
Pseudoasmatic symptoms Infectious pathology
• Immunodeficiencies
• Bronchiolitis
• Bronchitis obliterans
Tracheobronchial foreign body
Cystic fibrosis of the pancreas
Gastroesophageal reflux
Mediastinal tumors and adenopathies
Less frequent processes Congenital anomalies
• Laringo and tracheomalacia
• Vascular rings
Alpha-1 antitrypsin deficiency
Hypersensitivity pneumonitis
Pulmonary hemosiderosis
Alveolar proteinosis
Eosinophilic lung
Table 5. Most outstanding processes for differential diagnosis.
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In a large study (8310 mothers) in which the presence of respiratory symptoms that took place 
between 6 and 81 months after birth was investigated, the authors reached this conclusion:
1. Sixty-eight percent of the children never had episodes of wheezing .
2. Ten percent had them sporadically, with a prevalence between 18 and 42 months.
3. Eight percent presented them for a long time, between 30 and 69 months.
4. In 2% the prevalence was low until 19 months, increasing after 18 months.
5. Late onset in 5% of the children, in which the prevalence of sibilance lasted up to 42 months 
in 50% of them.
6. Persistent wheezy (7%) with 65% prevalence at 6 months and approximately 90% preva-
lence thereafter [14].
In a more recent study, the same authors analyze the need to assess the exhaled nitric oxide 
fraction (FeNO) together with the respiratory function, family history, and environment in 
which the child lives, in addition to the treatment received, facts that may condition the per-
sistence of the process for a longer time [15].
A study carried with the purpose of knowing if the different respiratory processes in young 
children could be related to breastfeeding and its duration finds above all a possible protec-
tion against viral infections, but it has not been possible to establish its participation in the 
establishment of phenotypes related to other respiratory processes.
It is really difficult to establish a certain diagnosis of asthma in the first years of life, since in 
many cases it is the evolution of symptoms over the years that allows confirming the diag-
nosis with support of the appropriate immuno-allergological study. The diagnosis of asthma 
will be reached by previously excluding other possible causes of dyspnea or wheezing. As a 
more frequent diagnostic alternative, “wheezing bronchitis” would be characterized by single 
or repeated episodes of dyspnea or wheezing and/or noisy breathing, of variable intensity, 
which may be febrile, which begin in the first year of life and do not continue more than the 
third year. In summary, in preschool children this respiratory episodes can be classified as 
(a) occasional, one episode every 4–6 weeks or less; (b) frequents, more of one episode in 
4–6 weeks, isolated intercrisis symptoms, mild; (c) moderate persistence, very frequent exac-
erbations, symptoms that interfere with daily activities and sleep; and (d) severe persistent, 
daily or almost daily symptoms, with frequent episodes of dyspnea.
Coinciding with these concepts, different phenotypes of bronchospasm pathology in children 
have been differentiated, distinguishing asthma and transient bronchitis (wheezy bronchitis) 
that encompassed various processes suffered by a group of children that after preschool age 
do not have bronchospasm, a consequence of the predisposing factors. However, it is not 
always easy to determine the phenotype of a certain patient, and it may even be that over 
time, as it evolves, there is a need to change the criteria. Hence the need to pay attention 
to the characteristics of the symptoms and their evolution, in addition to a whole series of 
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circumstances, such as the suffering other allergic processes by the same child (eczema, milk 
protein allergy), early onset of the clinic, or the existence of similar pathology among siblings, 
parents, or other close relatives, environmental contaminants, climate, etc. The lack of family 
history in approximately 20% of cases adds another obstacle to the diagnosis.
In most children, asthma begins in the first 5 years of life. Different studies indicate that 
between 15 and 35% of preschool children have had some episode of respiratory difficulty, 
accompanied or not by wheezing or other respiratory sounds (wheezing bronchitis); how-
ever, 60–65% of those children will not suffer a crisis after the third year.
Apart from asthma and wheezing bronchitis, many other bronchopulmonary diseases have an 
early start, with a symptomatology that may recall those processes, as more frequent, sinus-
itis, adenoiditis, mucoviscidosis, ciliary dyskinesia, various malformations, gastroesophageal 
reflux, etc., to be taken into account in all cases.
Physiological factors (reduced bronchial caliber, physiological vagal tone, immune imma-
turity) tend toward normalization, while pathological factors (familial atopy, congenital or 
acquired bronchial hyperresponsiveness) depend on their incidence and decrease or increase 
depending on the circumstance.
5. School age and teenagers
The asthmatic adolescent presents particular characteristics, in part conditioned by the teen-
ager’s personality but also, possibly, because this illness has a different expression than in 
other ages. It is a fact that an undetermined percentage of children improve when reach-
ing adolescence, even being free from symptoms in some asthma cases qualified as mild or 
moderate. Nevertheless no cases of severe asthma disappear totally at this age. Some unde-
termined factors, possibly hormone-related, might influence this improvement in males. It 
should be clarified if this improvement is real and definitive. Many children at this age, with 
sporadic and mild symptoms more or less frequent (coughing, mild dyspnea after exercise), 
get used to their illness and say they feel well, although it is not rare listen to whistling of 
different intensity. Even in asymptomatic cases, with normal auscultation, the spirometry 
presents disturbances that show bronchial obstruction.
The persistence of respiratory processes that begin at preschool age can occur if the pheno-
type corresponds to the existence of atopic predisposition or, also, in some children infected 
by rhinovirus (RV) [16]. At these ages, asthma derives predominantly from atopy in relation 
to Th2 lymphocytes (IgE), eosinophilia, and airway inflammation. Early initiation of adequate 
treatment avoids the persistence and/or severity of asthma at these ages, especially in cases 
in which asthma was considered mild or moderate. However, no case of severe asthma stops 
manifesting at this stage of life and may become chronic due to the persistence of obstruc-
tion of the airways, manifesting recurrently serious or episodic, when predisposing factors 
are scarce. The persistence of asthma in these ages may be due to the intensity of the atopy 
(association of atopic eczema) and the AHR; the process self-control, failure to comply or the 
abandon treatment and inadequate medication in the crisis; and family or work environment, 
smoking, powder, animals, etc.
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Some undetermined factors, possibly hormonal, must influence the improvement and also the 
inversion that occurs at this age, in terms of frequency by sex, with predominance in the female, 
predominant in adulthood. In some cases in which the symptomatology is very sporadic, how-
ever, spirometry can show alterations that reveal bronchial obstruction that will condition the 
subsequent evolution. However, in milder cases, it is possible that spirometry remains within nor-
mal limits, so the methacholine or histamine test can help demonstrate the hyperresponsiveness.
Four phenotypes related to responsible allergens (especially fungi) and AHR have been dis-
tinguished: [1] later sensitization to indoor allergens, [2] multiple early sensitization, [3] early 
sensitization to outdoor allergens (especially Alternaria) and later sensitization to indoor 
(including Aspergillus), and [4] early sensitization to indoor allergens and later sensitization 
to outdoor allergens [17, 18]. In some cases, asthma begins in adolescence, possibly due to the 
low familial predisposition of atopy (only uncles or grandparents) and only slight bronchial 
hyperresponsiveness, which is why it is possible that the environment or the beginning of 
smoking is responsible for its start [19].
At these ages, coming from the smallest ones or beginning in them, the following phenotypes 
and endotypes of asthma can be distinguished that usually extend until the adult age:
1. Eosinophilic: allergic, by aspirin, severe hypereosinophilic of late onset, and allergic bron-
chopulmonary mycosis
2. Prone to exacerbations: allergic, by aspirin, severe hypereosinophilic of late onset, wheez-
ing from a younger age, exacerbation by virus, and premenstrual syndrome
3. Related to obesity: obstruction of air flow, severe steroid dependence, severe hypereosino-
philic of late onset
4. Overexertion: athletes, wheezing from preschool age.
5. Fixed airflow limitation: noneosinophilic (neutrophilic)
6. Scarce response to steroids: neutrophilic, eosinophilic, obesity—airflow obstruction [1]
In cases of severe asthma, different clinical pictures can be distinguished, conditioned by the 
phenotype: [1] persistent chronic symptoms, [2] recurrent severe asthma exacerbations, [3] 
persistent airflow obstruction, and [4] brittle asthma: type 1 (persistent wild swing in peak 
flow) and type 2 (sudden acute deteriorations). In some of these variants, the aforementioned 
viruses (RSV) may be responsible.
One of the main problems at this age in the no compliance of medication. This feeling of well-
being makes the adolescent to stop it, using the drugs only when not feeling well and, frequently, 
in an uncontrolled way and not using the proper medication. Mortality in teenager asthma has 
been related to self-management of severe crisis, with insufficient or inappropriate medication.
6. Resulting processes
Summarizing the concepts presented, the coordination of the endotype and the phenotype 
are the basis for the establishment of these currently accepted tracheobronchial processes:
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1. Transient early wheezing: no family or analytical history of atopy; early onset and disap-
pearance between 3 and 5 years; decreased lung function, but recovered before 6 years 
of age; no bronchial hyperreactivity (normal methacholine test); and eosinophilia or high 
levels of IgE. Possible predispositions: prematurity, genetic (congenital reduction of func-
tional residual capacity (V
max
 FRC)), or environmental (smoking mother, irritants).
2. Non-atopic wheezing: beginning before 3 years of age, the majority (73% of cases) after 
viral infections (RSV, para-influenza, others), although infection by RSV before 3 years of 
age has been associated with the risk of persisting wheezing episode till 10 years of age. In 
general, there is no family history of atopy or clinical or analytical signs of it in the same 
patient: decreased lung function after infection and progressive normalization with maxi-
mum persistence of the process up to 13 years of age.
3. Atopic wheezing/asthma: in which there is no lack of familial atopic predisposition, it starts 
before 6 years (80%); early sensitization to pneumo-allergens; positive specific IgE and skin 
tests; frequent coincidence with associated allergic processes (rhinitis, eczema, urticaria); 
progressive deterioration of lung function and bronchial hyperreactivity; persistence that 
may reach adulthood, if adequate treatment is not carried out at an early stage (especially 
immunotherapy when indicated, anti-inflammatory, bronchodilators); and environmental 
measures [4, 20–23].
7. Controversies
Despite the evidence of the different ways of presenting the bronchospastic processes in the 
pediatric age, the evidence of the aforementioned predisposing factors has been questioned 
because there are several respiratory processes with similar symptoms but varying in the age 
of onset, persistence, family history, and coexistence or not with other processes of allergic 
cause (cutaneous, digestive). Likewise, the different coincidence of wheezing, atopy, or AHR 
can condition the different respiratory processes, based on the different uses of the term phe-
notype, such as:
1. Any observable trait (partial phenotype) includes signs, symptoms, measurements, and 
biological markers.
2. Clinically useful grouping defines groups that differ with respect to features of interest, 
e.g., risk factors, response to treatment, and prognosis.
3. Hypothesized disease entity defines a condition that is thought to represent a distinct dis-
ease entity.
These factors are the basis for doubting the reality of the phenotypes whose definition is also 
debatable, requiring a better definition of the term and its possible relationship with the afore-
mentioned respiratory processes. “In the meantime, we should treat phenotypes as exactly 
that the best current working hypothesis” how the authors of the work finish [24].
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